Health-related quality of life and treatment satisfaction in Chronic Lymphocytic Leukemia (CLL) patients on ibrutinib compared to other CLL treatments in a real-world US cross sectional study
Deering, Kathleen L, Sundaram, Murali, Harshaw, Qing, Trudeau, Jeremiah, Barrientos, Jacqueline Claudia
Published in PloS one (06.10.2022)
Published in PloS one (06.10.2022)
Get full text
Journal Article
Pitfalls of Current Diagnostic Criteria of Tumor Lysis Syndrome
Alhamid, Naji, Sabbagh, Bana, Alsarraj, Asmaa, Lerma, Edgar, Caza, Tiffany, Workeneh, Biruh, Barrientos, Jacqueline Claudia, Jhaveri, Kenar D.
Published in Kidney & blood pressure research (12.03.2024)
Published in Kidney & blood pressure research (12.03.2024)
Get full text
Journal Article
Health-related quality of life and treatment satisfaction in Chronic Lymphocytic Leukemia
Deering, Kathleen L, Sundaram, Murali, Harshaw, Qing, Trudeau, Jeremiah, Barrientos, Jacqueline Claudia
Published in PloS one (06.10.2022)
Published in PloS one (06.10.2022)
Get full text
Journal Article
Real-world outcomes by race in patients (pts) with chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL): Final analysis results from the informCLL registry
Barrientos, Jacqueline Claudia, Sharman, Jeff Porter, Gutierrez, Meghan E., Wu, Linda, Qureshi, Zaina P., Raz, Anat, Girardi, Vincent, Naganuma, Maoko, Ghosh, Nilanjan
Published in Journal of clinical oncology (01.06.2023)
Published in Journal of clinical oncology (01.06.2023)
Get full text
Journal Article
Analysis of racial disparities accounting for treatment received in chronic lymphocytic leukemia: A real-world cohort analysis
Kittai, Adam, Huang, Ying, Bhat, Seema Ali, Clark, Abi, Grever, Michael R., Roberts, Melyssa, Rogers, Kerry Anne, Teschemaker, Anna, Munoz-Sagastibelza, Maria, Woyach, Jennifer Ann, Barrientos, Jacqueline Claudia
Published in Journal of clinical oncology (01.06.2023)
Published in Journal of clinical oncology (01.06.2023)
Get full text
Journal Article
Prognostic testing and treatment patterns in Black patients (pts) with chronic lymphocytic leukemia (CLL) from the informCLL prospective, observational registry
Barrientos, Jacqueline Claudia, Mato, Anthony, Sharman, Jeff Porter, Brander, Danielle M., Gutierrez, Meghan E., Wu, Linda, Panjabi, Sumeet, Young, Alex, Upasani, Sandhya, Naganuma, Maoko, Ghosh, Nilanjan
Published in Journal of clinical oncology (01.06.2022)
Published in Journal of clinical oncology (01.06.2022)
Get full text
Journal Article
Phase 1/2 study of cirmtuzumab and ibrutinib in mantle cell lymphoma (MCL) or chronic lymphocytic leukemia (CLL)
Lee, Hun Ju, Choi, Michael Y., Siddiqi, Tanya, Barrientos, Jacqueline Claudia, Wierda, William G., Isufi, Iris, Tuscano, Joseph M., Lamanna, Nicole, Subbiah, Suki, Koff, Jean Louise, Leslie, Lori Ann, Goldenberg, Alec, Chung, Gina G., Breitmeyer, James Bradley, Hsu, Frank J., Wang, Michael, Jamieson, Catriona, Kipps, Thomas J.
Published in Journal of clinical oncology (20.05.2021)
Published in Journal of clinical oncology (20.05.2021)
Get full text
Journal Article
Health-related quality of life and treatment satisfaction in Chronic Lymphocytic Leukemia (CLL) patients on ibrutinib compared to other CLL treatments in a real-world US cross sectional study
Kathleen L. Deering, Murali Sundaram, Qing Harshaw, Jeremiah Trudeau, Jacqueline Claudia Barrientos
Published in PloS one (01.01.2022)
Get full text
Published in PloS one (01.01.2022)
Journal Article
Clinical activity of cirmtuzumab, an anti-ROR1 antibody, in combination with ibrutinib: Interim results of a phase Ib/II study in mantle cell lymphoma (MCL) or chronic lymphocytic leukemia (CLL)
Lee, Hun Ju, Choi, Michael Y., Siddiqi, Tanya, Wierda, William G., Barrientos, Jacqueline Claudia, Lamanna, Nicole, Goldenberg, Alec, Isufi, Iris, Tuscano, Joseph M., Subbiah, Suki, Weihe, Elizabeth Kristine, Ianopulos, Xen, Breitmeyer, James Bradley, Hsu, Frank J., Wang, Michael, Jamieson, Catriona HM, Kipps, Thomas J.
Published in Journal of clinical oncology (20.05.2020)
Published in Journal of clinical oncology (20.05.2020)
Get full text
Journal Article
Acalabrutinib in treatment-naïve chronic lymphocytic leukemia: Mature results from phase II study demonstrating durable remissions and long-term tolerability
Byrd, John C., Woyach, Jennifer Ann, Furman, Richard R., Martin, Peter, O'Brien, Susan Mary, Brown, Jennifer R., Stephens, Deborah Marie, Barrientos, Jacqueline Claudia, Devereux, Stephen, Hillmen, Peter, Pagel, John M., Hamdy, Ahmed M., Izumi, Raquel, Patel, Priti, Wang, Min Hui, Jain, Nitin, Wierda, William G.
Published in Journal of clinical oncology (20.05.2020)
Published in Journal of clinical oncology (20.05.2020)
Get full text
Journal Article
Final analysis from RESONATE: Six-year follow-up in patients (pts) with previously treated chronic lymphocytic leukemia or small lymphocytic lymphoma (CLL/SLL) on ibrutinib
Barr, Paul M., Munir, Talha, Brown, Jennifer R., O'Brien, Susan Mary, Barrientos, Jacqueline Claudia, Reddy, Nishitha M., Coutre, Steven, Tam, Constantine Si Lun, Mulligan, Stephen P., Jäger, Ulrich, Kipps, Thomas J., Moreno, Carol, Montillo, Marco, Burger, Jan Andreas, Byrd, John C., Hillmen, Peter, Dai, Sandra, Szoke, Anita, Dean, James P., Woyach, Jennifer Ann
Published in Journal of clinical oncology (20.05.2019)
Published in Journal of clinical oncology (20.05.2019)
Get full text
Journal Article
An evaluation of the chronic lymphocytic leukemia (CLL) international prognostic index as a prognostic tool in patients with relapsed/refractory CLL in idelalisib phase 3 randomized studies
Soumerai, Jacob Drobnyk, Barrientos, Jacqueline Claudia, Hallek, Michael, Kipps, Thomas J., Jones, Jeffrey Alan, Stilgenbauer, Stephan, Xing, Guan, Yao, Nai-Shun, Ysebaert, Loic, Zelenetz, Andrew David
Published in Journal of clinical oncology (20.05.2016)
Published in Journal of clinical oncology (20.05.2016)
Get full text
Journal Article
Tolerability & long-term disease control by IGHV mutation status among CLL patients on ibrutinib arm of E1912
Shanafelt, Tait D, Wang, Xin Victoria, Hanson, Curtis A, Paietta, Elisabeth, O'Brien, Susan M, Barrientos, Jacqueline Claudia, Jelinek, Diane F, Braggio, Esteban, Leis, Jose F, Zhang, Cong, Barr, Paul M, Cashen, Amanda F, Mato, Anthony R, Singh, Avina K, Mullane, Michael, Little, Richard F, Erba, Harry P, Stone, Richard M, Litzow, Mark R, Tallman, Martin S, Kay, Neil E
Published in Blood advances (20.08.2024)
Published in Blood advances (20.08.2024)
Get full text
Journal Article
Richter's syndrome (RS) in patients with chronic lymphocytic leukemia (CLL) on novel agent therapy
Davids, Matthew Steven, Huang, Ying, Rogers, Kerry Anne, Stern, Robert, Brown, Jennifer R., Thompson, Philip A., Brander, Danielle M., Danilov, Alexey Valeryevich, Ujjani, Chaitra Shankar, Parikh, Sameer Ashok, Barrientos, Jacqueline Claudia, Tam, Constantine, Woyach, Jennifer Ann
Published in Journal of clinical oncology (20.05.2017)
Published in Journal of clinical oncology (20.05.2017)
Get full text
Journal Article
A phase 2 study to assess the safety and efficacy of umbralisib (TGR-1202) in pts with CLL who are intolerant to prior BTK or PI3Kδ inhibitor therapy
Mato, Anthony R., Schuster, Stephen J., Lamanna, Nicole, Flinn, Ian, Barrientos, Jacqueline Claudia, Kambhampati, Suman, Cheson, Bruce D., Barr, Paul M., Pagel, John M., Reeves, James Andrew, Lansigan, Frederick, Pu, Jeffrey J., Skarbnik, Alan P., Fonseca, Gustavo A., Dorsey, Colleen, Luning Prak, Eline, Paskalis, Dana, Sportelli, Peter, Miskin, Hari P., Brander, Danielle M.
Published in Journal of clinical oncology (20.05.2018)
Published in Journal of clinical oncology (20.05.2018)
Get full text
Journal Article
A phase 1b trial of duvelisib, a PI3K-δ,γ inhibitor, in combination with obinutuzumab in patients with CLL/SLL previously treated with a Bruton’s tyrosine kinase inhibitor (BTKi)
Blachly, James Stewart, Brown, Jennifer R., Barrientos, Jacqueline Claudia, Jain, Nitin, Kelly, Virginia, Garnick, Stephanie, Rodstrom, Jill, Sweeney, Jennifer, Tang, Shijie, Byrd, John C.
Published in Journal of clinical oncology (20.05.2015)
Published in Journal of clinical oncology (20.05.2015)
Get full text
Journal Article
Outcomes of anticoagulant (AC) or antiplatelet (AP) use in patients (pts) with chronic lymphocytic leukemia (CLL) or indolent non-Hodgkin’s lymphoma (iNHL) in idelalisib (IDELA) trials
Barrientos, Jacqueline Claudia, Ghia, Paolo, Pagel, John, Salles, Gilles A., Sharman, Jeff Porter, Stilgenbauer, Stephan, Gurtovaya, Oksana, Kim, Yeonhee, Philip, Betsy, Zelenetz, Andrew David
Published in Journal of clinical oncology (20.05.2015)
Published in Journal of clinical oncology (20.05.2015)
Get full text
Journal Article
Patterns of hepatitis B reactivation and liver test abnormalities in patients with chronic lymphocytic leukemia (CLL) treated with idelalisib plus an anti-CD20 antibody
Zelenetz, Andrew David, Mato, Anthony R., Robak, Tadeusz, Jones, Jeffrey Alan, Pagel, John M., Barrientos, Jacqueline Claudia, Brown, Jennifer R., Montillo, Marco, Kipps, Thomas J., Dubowy, Ronald, Xing, Guan, Li, Julia, Hillmen, Peter
Published in Journal of clinical oncology (20.05.2016)
Published in Journal of clinical oncology (20.05.2016)
Get full text
Journal Article
Long-term efficacy and safety with ibrutinib (ibr) in previously treated chronic lymphocytic leukemia (CLL): Up to four years follow-up of the RESONATE study
Byrd, John C., Hillmen, Peter, O'Brien, Susan Mary, Barrientos, Jacqueline Claudia, Reddy, Nishitha M., Coutre, Steven, Tam, Constantine S., Mulligan, Stephen P., Jäger, Ulrich, Barr, Paul M., Furman, Richard R., Kipps, Thomas J., Thornton, Patrick, Pagel, John M., Burger, Jan Andreas, Jones, Jeffrey Alan, Dai, Sandra, Vezan, Remus N., James, Danelle Frances, Brown, Jennifer R.
Published in Journal of clinical oncology (20.05.2017)
Published in Journal of clinical oncology (20.05.2017)
Get full text
Journal Article
Long-term follow-up of a phase Ib trial of idelalisib (IDELA) in combination with chemoimmunotherapy (CIT) in patients (pts) with relapsed/refractory (R/R) CLL including pts with del17p/ TP53 mutation
Barrientos, Jacqueline Claudia, Coutre, Steven, De Vos, Sven, Flinn, Ian, Wagner-Johnston, Nina D., Schreeder, Marshall T., Sharman, Jeff Porter, Boyd, Thomas E., Rai, Kanti Roop, Leonard, John, Sorensen, Bess, Viggiano, Anthony, Jahn, Thomas Michael, Furman, Richard R.
Published in Journal of clinical oncology (20.05.2015)
Published in Journal of clinical oncology (20.05.2015)
Get full text
Journal Article